Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Posts Tagged ‘Julian Baker’

Peter Kolchinsky

Five Stocks To Buy According To Top Biotech-Focused Funds

Biotechnology is a very interesting industry to invest in, but also very complex. If you are looking for stocks that are most likely to see their value......(read more)
Felix Baker - Baker Bros.

The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3

Baker Bros. Advisors has arguably been the most successful healthcare-focused hedge fund on the Street in recent years. Founded by brothers Julian Baker......(read more)
Felix Baker - Baker Bros.

Incyte Corporation (INCY), Seattle Genetics, Inc. (SGEN) & Two More: Top Healthcare Hedge Fund Loves These Stocks

Baker Bros. Advisors is a fund managed by Julian Baker and Felix Baker that mainly invests in biotechnology companies, and today we are going to take......(read more)
Felix Baker - Baker Bros.

Aquinox Pharmaceuticals Inc (AQXP): Baker Bros. Advisors Pushes Stake to Over 45%

A newly-amended 13D filing with the Securities and Exchange Commission revealed that Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) has signed an Underwriting......(read more)
Felix Baker - Baker Bros.

Biocryst Pharmaceuticals Inc (BCRX): Baker Bros. Advisors Unloads Nearly 4 Million Shares

Julian Baker and Felix Baker‘s Baker Bros. Advisors recently filed an amended Form 13D with the SEC to report the sale of common shares of Biocryst......(read more)
Christian Leone Luxor Capital

Billionaire Leone Boosts Stake in This REIT, Ubben Sells More Shares of Motorola Solutions Inc. (MSI), Plus Two Other Hot Moves

It is generally believed that individuals seeking to become millionaires (and who isn’t?) need to think and act like millionaires. That’s probably......(read more)
Felix Baker - Baker Bros.

Seattle Genetics Inc (SGEN): Baker Bros. Keeps Buying Shares

Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors. Among other things......(read more)
Felix Baker - Baker Bros.

Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More

Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies......(read more)
Felix Baker - Baker Bros.

13D Filing: Baker Bros. Advisors Buys More Shares of Seattle Genetics Inc (SGEN)

Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors, by far the......(read more)
Felix Baker - Baker Bros.

Top 5 Healthcare Bets of World-Class Baker Bros. Advisors

Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker......(read more)
Felix Baker - Baker Bros.

Elite Hedge Funds Make Bigger Moves Into These 2 Stocks

Neal C. Bradsher‘s Broadwood Capital revealed in a recent Form 4 filing with the SEC that it has purchased an additional 2.43 million shares of......(read more)
Felix Baker - Baker Bros.

Baker Bros. Relentlessly Adding Shares Of One Biotech, Going Activist On Another

Julian Baker and Felix Baker’s Baker Bros. Advisors continues to relentlessly add shares to its position in Seattle Genetics, Inc. (NASDAQ:SGEN). In......(read more)
Health Practitioners

Don’t Miss White-Hot Baker Bros.’ New Healthcare Picks

At Insider Monkey, we track over 700 hedge funds and investment companies, which allows us to understand the market sentiment towards any given stock.......(read more)
Anacor Pharmaceuticals Inc (ANAC), NASDAQ:ANAC, Yahoo Finance,

Another Score For Baker Bros. As Anacor Pharmaceuticals Inc (ANAC) Soars 65% Premarket On Crisaborole Trial Success

Shares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) soared to a lofty $140.00 per share pre-market high today, or a whopping 65.47% higher than the stock......(read more)
pharma 3

Synageva Biopharma Corp (GEVA) Acquisition Helps Baker Bros. Advisors Top All Others In Q2 Returns

With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker‘s Baker Bros. Advisors is making a habit of hitting......(read more)
Felix Baker - Baker Bros.

Baker Bros. Advisors Hits the Jackpot with Pharmacyclics Inc (PCYC) Sale; Incyte Corporation (INCY) Among Fund’s Other Top Picks

Julian Baker and Felix Baker‘s Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015. AbbVie Inc......(read more)
Felix Baker - Baker Bros.

Mirati Therapeutics Inc. (MRTX): Baker Bros. Advisors Increases Stake in Growing Stock

Julian Baker and Felix Baker’s Baker Bros. Advisors recently disclosed an increase of around 929,700 shares to its position in Mirati Therapeutics,......(read more)
Navroz Udwadia - Falcon Edge Capital

Tekmira Pharmaceuticals Corporation (TKMR): Falcon Edge Capital Discloses 10% Passive Stake

Another one of the funds we track here at Insider Monkey has made a big move into Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), as it was revealed......(read more)
Peter Kolchinsky

Tekmira Pharmaceuticals Corporation (TKMR): RA Capital Management Discloses 10% Passive Stake

It was revealed in a filing yesterday with the U.S Securities and Exchange Commission that RA Capital Management has opened a large, passive position......(read more)
Felix Baker - Baker Bros.

Bellicum Pharmaceuticals Inc (BLCM): Baker Bros. Discloses 16% Passive Stake

As a new filing with the Securities and Exchange Commission showed, Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) has been added to the equity portfolio......(read more)
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA)

Vanda Pharmaceuticals Inc (VNDA): Deerfield Management Increases Exposure Following Positive Announcement

James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday. After adding more than 1......(read more)
Felix Baker - Baker Bros.

Seattle Genetics Inc. (SGEN), Cerus Corporation (CERS): Baker Bros. Advisors’ Latest Moves

Baker Bros. Advisors, the fund managed by Julian and Felix Baker disclosed changes in two of its activist positions last Thursday. The firm continued......(read more)
Aerie Pharmaceuticals

Deerfield Management Ups Stake in Aerie Pharmaceuticals Inc (AERI)

In a new filing with the Securities and Exchange Commission, James E. Flynn of Deerfield Management, has revealed a 6.05% stake in Aerie Pharmaceuticals......(read more)
Andreas Halvorsen

Triumph Group Inc (TGI), Intercept Pharmaceuticals Inc (ICPT), Zynga Inc (ZNGA): Viking Global’s Top 5 Small-Cap Picks

Small-cap picks from individual funds might provide investors with attractive investment options. In this article we will look into Andreas Halvorsen’......(read more)
Felix Baker - Baker Bros.

Felix Baker Raises Stake in Synageva BioPharma Corp (GEVA) Through Convention of Options

As a new form 4 filing with the Securities and Exchange Commission showed, Julian and Felix Bakers‘ Baker Bros Advisors, a fund focused on the......(read more)
Pharmacyclics, Inc. (NASDAQ:PCYC)

Baker Bros Reveals New Stake in Aquinox Pharmaceuticals (AQXP)

In a new filing with the SEC, Julian Baker and Felix Baker’s Baker Bros. Advisors revealed new stake in Aquinox Pharmaceuticals Inc (NASDAQ:AQXP).......(read more)
Genomic Health, Inc. (NASDAQ:GHDX)

Baker Bros. Advisors’ Latest Moves Involve Genomic Health, Inc. (GHDX), & Celsus Therapeutics PLC (ADR) (CLSXD)

Julian Baker and Felix Baker’s Baker Bros. Advisors have disclosed in a new filing with the SEC adding approximately 4,100 shares to their stake......(read more)
Arthur B Cohen and Joseph Healey, Healthcor Management LP

Five Hedge Fund Moves in Healthcare Sector From This Week

The healthcare sector is usually very attractive to investors, since the companies involved in it have a great potential to grow. According to Morningstar......(read more)
Incyte Corporation (NASDAQ:INCY)

The Baker Brothers Cut Their Position in Incyte Corporation

Julian and Felix Baker and their hedge fund, Baker Bros. Advisors, reported slicing their exposure at Incyte Corporation (NASDAQ:INCY) to 19.53 million......(read more)
Viropharma Inc (NASDAQ:VPHM)

Baker Bros. Decreases Exposure at Viropharma

Julian and Felix Baker‘s hedge fund, Baker Bros. Advisors, now holds around 4.4 million shares of Viropharma Inc (NASDAQ:VPHM), a newly amended......(read more)
MEI Pharma

Baker Bros. Advisors Sells Some MEI Pharma, Discloses a Massive Stake in Mirati Therapeutics

In a couple 13D filings with the SEC, Julian and Felix Baker‘s Baker Bros. Advisors reported a 19.9% stake in Mirati Therapeutics, Inc. (NASDAQ......(read more)
Mirati Therapeutics, Inc

Baker Bros. Buy Some Shares of Mirati Therapeutics

Baker Bros., Mirati Therapeutics: In a new form 4 from today, Julian and Felix Baker‘s Baker Bros. Advisors reported buying 400,000 shares of Mirati......(read more)
ynageva BioPharma Corp (NASDAQ:GEVA)

Is Synageva BioPharma a Buy? Baker Bros. Thinks So

Is Synageva BioPharma a buy? Baker Bros. Advisors, a hedge fund managed by Julian and Felix Baker with a focus on biotechnology, increased its stake......(read more)
ChemoCentryx Inc (NASDAQ:CCXI)

Biotech-Focused Hedge Fund is Bullish on ChemoCentryx Inc (CCXI)

Tracking the activity of hedge funds via their filings with the Securities and Exchange Commission is particularly crucial, since these filings reveal......(read more)
Kythera Biopharmaceuticals Inc (NASDAQ:KYTH)

What Hedge Funds Think About Kythera Biopharmaceuticals Inc (KYTH)

To the average investor, there are tons of methods market participants can use to track publicly traded companies. Two of the most useful are hedge fund......(read more)
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Hedge Fund Bets On Onyx Pharmaceuticals, Inc. (ONXX)

As fast as we can type this, Phill Gross and Robert Atchinson’s hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares......(read more)
Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Do Hedge Funds and Insiders Love Halozyme Therapeutics, Inc. (HALO)?

Is Halozyme Therapeutics, Inc. (NASDAQ:HALO) a good investment? Now, according to many investors, hedge funds are seen as delayed, outdated financial......(read more)
Repros Therapeutics Inc (NASDAQ:RPRX)

Repros Therapeutics Inc (RPRX): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

Is it smart to be bullish on Repros Therapeutics Inc (NASDAQ:RPRX)? To many of your peers, hedge funds are viewed as bloated, outdated financial vehicles......(read more)
XenoPort, Inc. (NASDAQ:XNPT)

Is XenoPort, Inc. (XNPT) Going to Burn These Hedge Funds?

Should XenoPort, Inc. (NASDAQ:XNPT) investors track the following data? At the moment, there are plenty of metrics market participants can use to monitor......(read more)
ArQule, Inc. (NASDAQ:ARQL)

What Hedge Funds Think About ArQule, Inc. (ARQL)

Is ArQule, Inc. (NASDAQ:ARQL) a good investment? In the 21st century investor’s toolkit, there are many metrics shareholders can use to monitor stocks......(read more)
Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)

Hedge Funds Are Selling Threshold Pharmaceuticals, Inc. (THLD)

Is it smart to be bullish on Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)? At the moment, there are tons of methods market participants can use to watch......(read more)
InterMune Inc (NASDAQ:ITMN)

InterMune Inc (ITMN): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged

What’s a smart InterMune Inc (NASDAQ:ITMN) investor to do? To many market players, hedge funds are perceived as delayed, old financial tools of......(read more)
Genomic Health, Inc. (NASDAQ:GHDX)

What Hedge Funds Think About Genomic Health, Inc. (GHDX)

In the 21st century investor’s toolkit, there are plenty of indicators investors can use to monitor stocks. Some of the best are hedge fund and insider......(read more)
QLT Inc. (USA) (NASDAQ:QLTI)

QLT Inc. (USA) (QLTI): Are Hedge Funds Right About This Stock?

Should investors bullish on QLT Inc. (USA) (NASDAQ:QLTI) consider the following data? In the financial world, there are many indicators shareholders......(read more)
Incyte Corporation (NASDAQ:INCY)

Incyte Corporation (INCY): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?

Should investors be bullish on Incyte Corporation (NASDAQ:INCY)? In the 21st century investor’s toolkit, there are many gauges shareholders can use......(read more)
Viropharma Inc (NASDAQ:VPHM)

Viropharma Inc (VPHM): Are Hedge Funds Right About This Stock?

Is Viropharma Inc (NASDAQ:VPHM) a good investment? If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era......(read more)
Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL)

Auxilium Pharmaceuticals, Inc. (AUXL): Are Hedge Funds Right About This Stock?

To many of your fellow readers, hedge funds are assumed to be useless, old investment vehicles of a period lost to current times. Although there are more......(read more)
Pharmacyclics, Inc. (NASDAQ:PCYC)

What Hedge Funds Think About Pharmacyclics, Inc. (PCYC)

In today’s marketplace, there are many metrics market participants can use to track publicly traded companies. A pair of the most innovative are hedge......(read more)
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

This Metric Says You Are Smart to Sell Ariad Pharmaceuticals, Inc. (ARIA)

In the eyes of many investors, hedge funds are seen as overrated, old financial tools of a forgotten age. Although there are over 8,000 hedge funds in......(read more)
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX)

Onyx Pharmaceuticals, Inc. (ONXX) Investors: Listen Up

Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) investors: listen up. In the 21st century investor’s toolkit, there are tons of metrics shareholders can use......(read more)